1. Home
  2. ETB vs SRDX Comparison

ETB vs SRDX Comparison

Compare ETB & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETB
  • SRDX
  • Stock Information
  • Founded
  • ETB 2005
  • SRDX 1979
  • Country
  • ETB United States
  • SRDX United States
  • Employees
  • ETB N/A
  • SRDX N/A
  • Industry
  • ETB Investment Bankers/Brokers/Service
  • SRDX Medical/Dental Instruments
  • Sector
  • ETB Finance
  • SRDX Health Care
  • Exchange
  • ETB Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • ETB 363.4M
  • SRDX 416.1M
  • IPO Year
  • ETB N/A
  • SRDX 1998
  • Fundamental
  • Price
  • ETB $13.99
  • SRDX $29.02
  • Analyst Decision
  • ETB
  • SRDX Buy
  • Analyst Count
  • ETB 0
  • SRDX 3
  • Target Price
  • ETB N/A
  • SRDX $43.00
  • AVG Volume (30 Days)
  • ETB 71.8K
  • SRDX 69.2K
  • Earning Date
  • ETB 01-01-0001
  • SRDX 04-30-2025
  • Dividend Yield
  • ETB 8.23%
  • SRDX N/A
  • EPS Growth
  • ETB N/A
  • SRDX N/A
  • EPS
  • ETB N/A
  • SRDX N/A
  • Revenue
  • ETB N/A
  • SRDX $121,575,000.00
  • Revenue This Year
  • ETB N/A
  • SRDX N/A
  • Revenue Next Year
  • ETB N/A
  • SRDX $3.70
  • P/E Ratio
  • ETB N/A
  • SRDX N/A
  • Revenue Growth
  • ETB N/A
  • SRDX N/A
  • 52 Week Low
  • ETB $11.59
  • SRDX $26.00
  • 52 Week High
  • ETB $14.08
  • SRDX $42.44
  • Technical
  • Relative Strength Index (RSI)
  • ETB 61.08
  • SRDX 52.37
  • Support Level
  • ETB $13.71
  • SRDX $28.34
  • Resistance Level
  • ETB $13.94
  • SRDX $29.65
  • Average True Range (ATR)
  • ETB 0.15
  • SRDX 0.79
  • MACD
  • ETB 0.01
  • SRDX 0.16
  • Stochastic Oscillator
  • ETB 82.00
  • SRDX 62.29

About ETB Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund of Beneficial Interest

Eaton Vance Tax-Managed Buy-Write Income Fund is a United States-based diversified closed ended management investment company. The fund's investment objective is to provide current income and gains, with a secondary objective of capital appreciation. It invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of aerospace and defense, banks, biotechnology, chemicals, consumer finance, industrial conglomerates, and others.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: